GERMAN cultivator Demecan has welcomed proposals which will see all cannabis for its forthcoming adult-use market grown domestically.
The Traffic-Light Coalition’s policy pathway for a regulated market was unveiled by Health Minister Karl-Lauterbach (SPD) last week, as reported in BusinessCann.
One of the key points is its intention to ensure the market is solely supplied by German-domiciled cultivators, and as the sole, licensed, domestic, medical cannabis grower in the country Demecan is naturally pleased with this pathway.
Speaking to BusinessCann Dr Constantin von der Groeben, a Co-founder and Managing Director, said it is currently in talks with potential investors as it looks to expand its cultivation footprint.
‘We Can Start Investing’
“Last week’s news is very interesting and exciting for Demecan and the industry as a whole. The big news is that there will be no imports.
“That has immediately helped us, it means we can start investing, raising more money, and others are doing the same.
“It is important to know there will be no imports into Germany so that money can now be invested in cultivation capacity, rather than relying on an international supply network.
“The key element is that if imports had been left open we would not have invested into German cultivation landscape and, what would have happened if, say, next year the EU or international bodies would not allow imports? We would be in a position where, come 2024 and a legalised cannabis market, we would have no products.
“With this clarity German companies can establish new facilities and we will be ready to deliver when the market becomes legal.